banner
Cytochrome P450 inhibitor, ODM-204, Purity ≥98%
Inquiry

Cat. No.: X24-08-YM411

Cytochrome P450 inhibitor, ODM-204, Purity ≥98%

Synonym: 1642818-64-1; ODM204; ODM 204; 4-[[(1R)-3-Imidazol-1-yl-6,6-dimethylcyclohex-2-en-1-yl]-methylamino]-2-(trifluoromethyl)benzonitrile

  • CAS Number: 1642818-64-1
  • Compound CID: 121317454
img
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
ODM-204 is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Weight
374.4
Molecular Formula
C20H21F3N4
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
ODM-204 is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of prostate cancer by interfering with androgen biosynthesis, similar to other CYP17A1 inhibitors.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.